HomeCompareCRWRF vs MO

CRWRF vs MO: Dividend Comparison 2026

CRWRF yields 1.84% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MO wins by $55.2K in total portfolio value· pulled ahead in Year 5
10 years
CRWRF
CRWRF
● Live price
1.84%
Share price
$24.20
Annual div
$0.44
5Y div CAGR
12%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.9K
Annual income
$702.06
Full CRWRF calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — CRWRF vs MO

📍 MO pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRWRFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRWRF + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRWRF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRWRF
Annual income on $10K today (after 15% tax)
$156.23/yr
After 10yr DRIP, annual income (after tax)
$596.75/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, MO beats the other by $25,038.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRWRF + MO for your $10,000?

CRWRF: 50%MO: 50%
100% MO50/50100% CRWRF
Portfolio after 10yr
$52.5K
Annual income
$15,430.61/yr
Blended yield
29.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

CRWRF
No analyst data
Altman Z
4.6
Piotroski
7/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRWRF buys
0
MO buys
0
No recent congressional trades found for CRWRF or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRWRFMO
Forward yield1.84%6.36%
Annual dividend / share$0.44$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR12%22.6%
Portfolio after 10y$24.9K$80.1K
Annual income after 10y$702.06$30,159.17
Total dividends collected$4.1K$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: CRWRF vs MO ($10,000, DRIP)

YearCRWRF PortfolioCRWRF Income/yrMO PortfolioMO Income/yrGap
1$10,906$205.86$10,570$780.30+$336.00CRWRF
2$11,904$235.00$11,381$1,032.90+$523.00CRWRF
3$13,006$268.50$12,535$1,392.73+$471.00CRWRF
4$14,224$307.05$14,193$1,920.91+$31.00CRWRF
5← crossover$15,571$351.49$16,618$2,723.68$1.0KMO
6$17,063$402.76$20,263$3,993.80$3.2KMO
7$18,720$462.00$25,936$6,098.36$7.2KMO
8$20,561$530.53$35,166$9,775.01$14.6KMO
9$22,610$609.93$51,026$16,597.78$28.4KMO
10$24,895$702.06$80,113$30,159.17$55.2KMO

CRWRF vs MO: Complete Analysis 2026

CRWRFStock

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers InSight Denials to analyze, track, trend, and report on denial data; Trisus Healthcare Intelligence, a solution that provides insights into resource consumption on the patient level; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Sentrex 330; Referral Verification System; and Sentry Core, a solution that simplifies the complexities of pharmacy procurement, utilization, and compliances. Further, it offers appeal and professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Full CRWRF Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this CRWRF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRWRF vs SCHDCRWRF vs JEPICRWRF vs OCRWRF vs KOCRWRF vs MAINCRWRF vs PMCRWRF vs BTICRWRF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.